Receptor-ligand supplementation via a self-cleaving 2A peptide–based gene therapy promotes CNS axonal transport with functional recoveryTasneem Khatib(University of Cambridge), Keith R. Martin(University of Cambridge)Science AdvancesMarch 31, 202110.1126/sciadv.abd2590Cited by 34SaveCiteExport RISWatch citationsRelated PapersDesign of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons|Human Gene Therapy|2018|43